Thyroid, infection drugs get fresh safety warnings after national review

NEW DELHI: Two widely used medications, the antibiotic doxycycline and the thyroid drug carbimazole, are set to carry stronger safety warnings following a comprehensive national review. The review was conducted to ensure patient safety and address potential risks associated with these drugs. Health authorities have highlighted the importance of these warnings in informing both healthcare providers and patients about the possible adverse effects. The antibiotic doxycycline, commonly prescribed for a range of infections, will now include warnings about rare but serious side effects, such as increased sensitivity to sunlight and potential liver damage. Meanwhile, carbimazole, used in the management of hyperthyroidism, will have updated warnings regarding its potential to cause birth defects and other serious health issues if used during pregnancy. These changes aim to enhance patient awareness and encourage more informed decision-making in consultation with healthcare professionals. The decision to update these warnings reflects a growing emphasis on drug safety and the proactive measures being taken by health authorities to mitigate risks. Patients currently using these medications are advised to consult their doctors for further guidance and to discuss any concerns they may have. The updated safety information will be made available to the public through revised medication labels and informational leaflets, ensuring that all stakeholders are adequately informed.

— Authored by Next24 Live